Reversal of ischemic cardiomyopathy with Sca-1+ stem cells modified with multiple growth factors.
<h4>Background</h4>We hypothesized that bone marrow derived Sca-1+ stem cells (BM Sca-1+) transduced with multiple therapeutic cytokines with diverse effects will induce faster angiomyogenic differentiation in the infarcted myocardium.<h4>Methods and results</h4>BM Sca-1+ wer...
Guardado en:
Autores principales: | Ning Li, Zeeshan Pasha, Muhammad Ashraf |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6643509ca2cd41c89e9a1f6b6c753664 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Establishment of a novel murine model of ischemic cardiomyopathy with multiple diffuse coronary lesions.
por: Hajime Nakaoka, et al.
Publicado: (2013) -
Mitochondrial haplogroups H and J: risk and protective factors for ischemic cardiomyopathy.
por: Mariana Fernández-Caggiano, et al.
Publicado: (2012) -
Sca-1 identifies a trophoblast population with multipotent potential in the mid-gestation mouse placenta
por: Bryony V. Natale, et al.
Publicado: (2017) -
Clinical Outcomes in Patients with Ischemic versus Non-Ischemic Cardiomyopathy after Angiotensin-Neprilysin Inhibition Therapy
por: Mohammad Abumayyaleh, et al.
Publicado: (2021) -
Development of a nurse-paramedic model for acute STEMI/SCA care in India
por: T. Erickson, et al.
Publicado: (2016)